miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
2015 ◽
Vol 47
(5)
◽
pp. e162-e162
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 5
(1)
◽
pp. 38-42
Keyword(s):
Keyword(s):